Fluvoxamine EP Impurity I CAS 88699-84-7
| CAS No. | 88699-84-7 |
| Molecular Formula | C13H16F3NO2 |
| Molecular Weight | 275.27 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
As a certified reference material (CRM), Fluvoxamine EP Impurity I meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Fluvoxamine EP Impurity I (CAS 88699-84-7) is a certified pharmaceutical impurity reference standard with the molecular formula C13H16F3NO2 and a molecular weight of 275.27 g/mol.
The molecular framework of Fluvoxamine EP Impurity I (C13H16F3NO2) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, fluorine substitution. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
Physical & Chemical Properties
| Molecular Formula | C13H16F3NO2 |
| Molecular Weight | 275.27 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 5.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1982 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 1 |
Related Fluvoxamine Standards
- Fluvoxamine impurity 40 (CAS CATO-C4X-195140)
- Fluvoxamine impurity 41 (CAS CATO-C4X-195141)
- Fluvoxamine Impurity 15 (CAS 61718-83-0)
- Fluvoxamine EP Impurity A (CAS 1217216-82-4)
- Fluvoxamine impurity 42 (CAS CATO-C4X-195142)
- Fluvoxamine Impurity 53 (CAS CATO-C4X-195153)
- Fluvoxamine EP Impurity D (CAS 61718-80-7)
- Fluvoxamine Impurity 27 (CAS CATO-C4X-195127)
Recommended Standards
- 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl) phenyl] -, oxime (CAS 61747-22-6)
- Sitagliptin Impurity 101 (CAS CATO-C4X-1144101)
- 2738AE 3-{[4-(Trifluoromethoxy)phenoxy]methyl}piperidine 405090-60-0 C13H16F3NO2 (CAS 405090-60-0)
- Levocabastine impurity 17 (CAS CATO-C4X-228917)
- Voriconazole Impurity 67 (CAS CATO-C4X-136667)
- Cefdinir Impurity 77 (CAS 101156-40-5)
- Semaglutide impurity 66 (CAS CATO-C4X-222666)
- 2-(2-(5-(Trichloromethyl)-1,3,4-oxadiazol-2-yl)vinyl)benzofuran-6-ol (CAS 106579-64-0)
- Ethyl 4-(4-piperidinylmethoxy)benzoatehydrochloride (CAS 1219979-53-9)
- 4-Bromo-7-chloro-6-methoxy-2-methylquinoline (CAS 1378260-27-5)
- Tert-butyl-d-cysteine (CAS 300583-35-1)
- 1-Bromo-3-(1,1,2,2,2-pentafluoroethoxy)benzene stabilized over potassium carbonate (CAS 59935-56-7)
- 6,7-Dihydrobenzo[b]thiophen-4-one (CAS 13414-95-4)
- (Tyr9)-Cholecystokinin Octapeptide (sulfated) (H-9770.0005) (CAS 96607-61-3)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com